EHS
EHS

FDA expands approval of cell-based flu vaccine down to age 6 months



The FDA expanded the age indication of the only cell-based inactivated influenza vaccine approved for use in the United States to include children as young as age 6 months, the vaccine’s manufacturer announced Friday.
The expanded age indication means that Flucelvax Quadrivalent (IIV4c, Seqirus) is available as an alternative to traditional egg-based vaccines for anyone in the U.S. who is eligible to receive an influenza vaccine. Previously, the vaccine was available for people as young as age 2 years.
“As one of the world’s largest influenza vaccine manufacturers, we

Source link

EHS
Back to top button